Clinical trials are key in the advancement of spine care. Patients who qualify may benefit by receiving expert care at leading medical facilities. These same patients are paving the way for new technologies to help future patients, as well.
The identification of genetic markers linked to Scoliosis and Degenerative Disc Disease. By understanding the molecular causes for these conditions, Axial Biotech hopes to be able to develop diagnostic/prognostic tests and potentially improved treatment options. Individuals who will be considered for eligibility include: Men, women, and children who have a diagnosis of Scoliosis or Degenerative Disc Disease.
The coflex medical device is in the new generation of dynamic stabilization implants designed to reduce nerve compression and create spinal stability while working to return the spine to a state that more closely resembles its normal physiology. A clinical research study is currently enrolling patients to determine the safety and effectiveness of the coflex dynamic stabilization implant as compared to pedicle screw fixation and spinal fusion.
The purpose of this study is to determine if the ACADIA™ Facet Replacement System is effective in the treatment of lumbar spinal stenosis. The primary objective of the study is to evaluate the overall success rate of the ACADIA™ Facet Replacement System in patients with lumbar spinal stenosis when compared to a posterior spinal fusion control.
The Crosstrees™ System uses a fabric Pod to control the delivery of bone cement to fractured vertebral bodies. This study is being performed to evaluate the Crosstrees System performance in reducing pain and decreasing the risk of cement leakage associated with vertebroplasty and kyphoplasty.